ANI Pharmaceuticals Inc (ANIP) Insider Trading
- $2,005,711.60
- $105,215,251.21
- Dec. 17, 2024
- Muthusamy Shanmugam
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Dec. 17, 2024 | CFO | 7,500 | $55.79 | Sell | $418,425.00 | |
Dec. 11, 2024 | SVP | 1,000 | $60.00 | Sell | $60,000.00 | |
Nov. 26, 2024 | CEO | 33,481 | $57.99 | Sell | $1,941,563.19 | |
Oct. 14, 2024 | VP | 250 | $57.19 | Sell | $14,297.50 | |
Sept. 13, 2024 | VP | 250 | $56.82 | Sell | $14,205.00 | |
Aug. 13, 2024 | VP | 250 | $59.62 | Sell | $14,905.00 | |
July 17, 2024 | COO | 14,257 | $63.16 | Sell | $900,472.12 | |
July 15, 2024 | COO | 11,000 | $63.38 | Sell | $697,180.00 | |
July 12, 2024 | VP | 250 | $64.91 | Sell | $16,227.50 | |
July 1, 2024 | SVP | 20,000 | $63.44 | Sell | $1,268,800.00 | |
June 21, 2024 | COO | 20,000 | $58.90 | Sell | $1,178,000.00 | |
June 13, 2024 | VP | 250 | $63.80 | Sell | $15,950.00 | |
June 5, 2024 | SVP | 2,985 | $67.00 | Sell | $199,995.00 | |
June 4, 2024 | CFO | 5,000 | $63.58 | Sell | $317,900.00 | |
June 3, 2024 | SVP | 20,000 | $64.41 | Sell | $1,288,200.00 | |
May 21, 2024 | Insider | 2,000 | $61.61 | Sell | $123,220.00 | |
May 20, 2024 | COO | 12,855 | $61.81 | Sell | $794,567.55 | |
May 17, 2024 | COO | 5,836 | $62.09 | Sell | $362,357.24 | |
May 16, 2024 | Director | 2,000 | $63.87 | Sell | $127,740.00 | |
May 15, 2024 | COO | 14,850 | $65.86 | Sell | $978,021.00 | |
May 14, 2024 | CEO | 16,669 | $66.10 | Sell | $1,101,820.90 | |
May 13, 2024 | VP | 250 | $67.69 | Sell | $16,922.50 | |
May 1, 2024 | SVP | 20,000 | $66.62 | Sell | $1,332,400.00 | |
April 19, 2024 | COO | 16,809 | $65.17 | Sell | $1,095,442.53 | |
April 17, 2024 | COO | 9,520 | $65.40 | Sell | $622,608.00 | |
April 15, 2024 | COO | 7,414 | $66.33 | Sell | $491,770.62 | |
April 12, 2024 | VP | 250 | $67.79 | Sell | $16,947.50 | |
April 1, 2024 | SVP | 20,000 | $67.25 | Sell | $1,345,000.00 | |
March 11, 2024 | CFO | 7,787 | $65.55 | Sell | $510,437.85 | |
March 8, 2024 | CEO | 16,292 | $67.13 | Sell | $1,093,681.96 | |
March 7, 2024 | COO | 15,085 | $66.35 | Sell | $1,000,889.75 | |
March 7, 2024 | SVP | 24,338 | $66.37 | Sell | $1,615,313.06 | |
March 6, 2024 | CEO | 28,965 | $65.52 | Sell | $1,897,786.80 | |
March 5, 2024 | COO | 10,093 | $65.35 | Sell | $659,577.55 | |
Feb. 13, 2024 | VP | 250 | $56.04 | Sell | $14,010.00 | |
Jan. 22, 2024 | COO | 5,692 | $55.95 | Sell | $318,467.40 | |
Jan. 18, 2024 | COO | 9,784 | $55.30 | Sell | $541,055.20 | |
Jan. 16, 2024 | COO | 5,000 | $55.63 | Sell | $278,150.00 | |
Jan. 12, 2024 | VP | 250 | $56.43 | Sell | $14,107.50 | |
Dec. 18, 2023 | COO | 13,026 | $52.44 | Sell | $683,083.44 | |
Dec. 15, 2023 | COO | 11,974 | $52.44 | Sell | $627,916.56 | |
Dec. 11, 2023 | VP | 250 | $49.21 | Sell | $12,302.50 | |
Nov. 16, 2023 | COO | 6,448 | $51.66 | Sell | $333,103.68 | |
Nov. 15, 2023 | SVP | 2,622 | $53.81 | Sell | $141,089.82 | |
Nov. 14, 2023 | COO | 22,095 | $53.17 | Sell | $1,174,791.15 | |
Oct. 18, 2023 | COO | 6,242 | $57.78 | Sell | $360,662.76 | |
Oct. 16, 2023 | COO | 13,063 | $58.31 | Sell | $761,703.53 | |
Oct. 13, 2023 | COO | 11,937 | $57.58 | Sell | $687,332.46 | |
Oct. 2, 2023 | SVP | 20,000 | $56.48 | Sell | $1,129,600.00 | |
Sept. 18, 2023 | COO | 8,425 | $61.64 | Sell | $519,317.00 |
Insiders are both buying and selling ANI Pharmaceuticals Inc stock.
The insider traders at ANI Pharmaceuticals Inc are: Muthusamy Shanmugam, Meredith Cook, Chad Gassert, Tracy Marshbanks, James G Marken, Meridian Venture Partners Ii L, Arthur Przybyl, Nikhil Lalwani, Robert W Schrepfer, Patrick D Walsh, Thomas Haughey, Ross J Mangano, Stephen P Carey, Ori Gutwerg, Krista Davis, Daniel Raynor, Jeanne Thoma, Christopher Mutz, Ross Mangano, David Nash, Antonio R Pera, and Renee P Tannenbaum
The most active insider trader at ANI Pharmaceuticals Inc is Muthusamy Shanmugam with 32 trades.
Meridian Venture Partners Ii L has sold the most ANI Pharmaceuticals Inc stock with a total value of $35,990,656.25.
Patrick D Walsh has bought the most ANI Pharmaceuticals Inc stock with a total value of $846,760.00.
The most recent insider trade for ANI Pharmaceuticals Inc was on Dec. 17, 2024.
The single biggest insider buy for ANI Pharmaceuticals Inc was from Patrick D Walsh with a total value of $307,800.00 on Aug. 10, 2020.
The single biggest insider sell for ANI Pharmaceuticals Inc was from Meridian Venture Partners Ii L with a total value of $11,700,000.00 on Aug. 16, 2023.